These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 38062390)
1. The aetiology and burden of myeloproliferative neoplasms in the United Kingdom: the MyelOproliferative neoplasmS: an In-depth case-control (MOSAICC) study protocol. Abutheraa N; Tarburn EL; McShane CM; Duncombe A; McMullin MF; Anderson LA BMC Cancer; 2023 Dec; 23(1):1207. PubMed ID: 38062390 [TBL] [Abstract][Full Text] [Related]
2. Aetiology of Myeloproliferative Neoplasms. McMullin MF; Anderson LA Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640679 [TBL] [Abstract][Full Text] [Related]
3. Genetic association between germline JAK2 polymorphisms and myeloproliferative neoplasms in Hong Kong Chinese population: a case-control study. Koh SP; Yip SP; Lee KK; Chan CC; Lau SM; Kho CS; Lau CK; Lin SY; Lau YM; Wong LG; Au KL; Wong KF; Chu RW; Yu PH; Chow EY; Leung KF; Tsoi WC; Yung BY BMC Genet; 2014 Dec; 15():147. PubMed ID: 25526816 [TBL] [Abstract][Full Text] [Related]
4. Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms. Anderson LA; Duncombe AS; Hughes M; Mills ME; Wilson JC; McMullin MF Am J Hematol; 2012 Feb; 87(2):175-82. PubMed ID: 22076943 [TBL] [Abstract][Full Text] [Related]
7. The MOSAICC study: Assessing feasibility for biological sample collection in epidemiology studies and comparison of DNA yields from saliva and whole blood samples. James G; McMullin MF; Duncombe AS; Clarke M; Anderson LA Ann Hum Genet; 2018 Mar; 82(2):114-118. PubMed ID: 29076129 [TBL] [Abstract][Full Text] [Related]
8. Relationship of JAK2 (V617F) Allelic Burden with Clinico- Haematological Manifestations of Philadelphia-Negative Myeloproliferative Neoplasms. Yow KS; Liu X; Chai CN; Tung ML; Yan B; Christopher D; Ong KH; Ooi MG Asian Pac J Cancer Prev; 2020 Sep; 21(9):2805-2810. PubMed ID: 32986384 [TBL] [Abstract][Full Text] [Related]
9. JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients. Tanaka M; Yujiri T; Ito S; Okayama N; Takahashi T; Shinohara K; Azuno Y; Nawata R; Hinoda Y; Tanizawa Y Int J Hematol; 2013 Mar; 97(3):409-13. PubMed ID: 23430670 [TBL] [Abstract][Full Text] [Related]
12. Focus on the epigenome in the myeloproliferative neoplasms. Kim E; Abdel-Wahab O Hematology Am Soc Hematol Educ Program; 2013; 2013():538-44. PubMed ID: 24319229 [TBL] [Abstract][Full Text] [Related]
13. Disabled, invisible and dismissed-The lived experience of fatigue in people with myeloproliferative neoplasms. Bradford A; Young K; Whitechurch A; Burbury K; Pearson EJM Cancer Rep (Hoboken); 2023 Jan; 6(1):e1655. PubMed ID: 35705529 [TBL] [Abstract][Full Text] [Related]
14. High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms. Chatambudza M; Skhosana L; Ketseoglou I; Wiggill T Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758219 [TBL] [Abstract][Full Text] [Related]
15. Advances in understanding the pathogenesis of familial myeloproliferative neoplasms. Rumi E; Cazzola M Br J Haematol; 2017 Sep; 178(5):689-698. PubMed ID: 28444727 [TBL] [Abstract][Full Text] [Related]
16. Modifiable Lifestyle and Medical Risk Factors Associated With Myeloproliferative Neoplasms. Duncombe AS; Anderson LA; James G; de Vocht F; Fritschi L; Mesa R; Clarke M; McMullin MF Hemasphere; 2020 Feb; 4(1):e327. PubMed ID: 32072143 [TBL] [Abstract][Full Text] [Related]
17. Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia. Benton CB; Boddu PC; DiNardo CD; Bose P; Wang F; Assi R; Pemmaraju N; Kc D; Pierce S; Patel K; Konopleva M; Ravandi F; Garcia-Manero G; Kadia TM; Cortes J; Kantarjian HM; Andreeff M; Verstovsek S Cancer; 2019 Jun; 125(11):1855-1866. PubMed ID: 30811597 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in myeloproliferative neoplasms: Causes and consequences. O'Sullivan J; Mead AJ Adv Biol Regul; 2019 Jan; 71():55-68. PubMed ID: 30528537 [TBL] [Abstract][Full Text] [Related]
19. The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey. Harrison CN; Koschmieder S; Foltz L; Guglielmelli P; Flindt T; Koehler M; Mathias J; Komatsu N; Boothroyd RN; Spierer A; Perez Ronco J; Taylor-Stokes G; Waller J; Mesa RA Ann Hematol; 2017 Oct; 96(10):1653-1665. PubMed ID: 28780729 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis- and Prognosis-Related Gene Alterations in Morishita S; Komatsu N Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188 [No Abstract] [Full Text] [Related] [Next] [New Search]